Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shilo Lefresene"'
Autor:
Robert Olson, Mitchell Liu, Alanah Bergman, Sonya Lam, Fred Hsu, Benjamin Mou, Tanya Berrang, Ante Mestrovic, Nick Chng, Derek Hyde, Quinn Matthews, Chad Lund, Daniel Glick, Howard Pai, Parminder Basran, Hannah Carolan, Boris Valev, Shilo Lefresene, Scott Tyldesley, Devin Schellenberg
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background Oligometastases refer to a state of disease where cancer has spread beyond the primary site, but is not yet widely metastatic, often defined as 1–3 or 1–5 metastases in number. Stereotactic ablative radiotherapy (SABR) is an e
Externí odkaz:
https://doaj.org/article/2cd625d1c2aa49488bdd64c1b19744d5
Autor:
M. Liu, Howard Pai, C.R. Lund, Scott Tyldesley, Derek Hyde, Alanah Bergman, Quinn Matthews, Benjamin Mou, Fred Hsu, Ante Mestrovic, Sonya Lam, Tanya Berrang, Robert Olson, Daniel Glick, Boris Valev, Nick Chng, Devin Schellenberg, Parminder S. Basran, Hannah Carolan, Shilo Lefresene
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Background: Oligometastases refer to a state of disease where cancer has spread beyond the primary site, but is not yet widely metastatic, often defined as 1–3 or 1–5 metastases in number. Stereotactic ablative radiotherapy (SABR) is an emerging
Autor:
Olson, Robert, Liu, Mitchell, Bergman, Alanah, Lam, Sonya, Hsu, Fred, Mou, Benjamin, Berrang, Tanya, Mestrovic, Ante, Chng, Nick, Hyde, Derek, Matthews, Quinn, Lund, Chad, Glick, Daniel, Pai, Howard, Basran, Parminder, Carolan, Hannah, Valev, Boris, Shilo Lefresene, Tyldesley, Scott, Schellenberg, Devin
Dose constraints used for SABR-5 trial. These are based on the AAPM TG 101, SABR-COMET, SC-24 trials as well as most updated references. If any structure is not listed, the constraints may be calculated using the linear quadratic formula from accep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76bf40a0cc65555b930fe0259facb549